Navigation Links
PDI Reports 2011 Fourth Quarter and Year End Financial Results
Date:3/7/2012

onciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures.

The company also discusses Adjusted EBITDA on a forward-looking basis as part of its 2012 Outlook.
The company is unable to present a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable forward-looking GAAP financial measure because management cannot predict, with sufficient reliability, operating income and other potential non-cash expenses. Adjusted EBITDA is a metric used by management to measure liquidity.
Adjusted EBITDA is defined as operating income (loss), plus depreciation and amortization, non-cash stock-based compensation, and other non-cash expenses.

On November 3, 2010, PDI acquired 100% of the membership interest in Group DCA for approximately $24 million plus potential future payments, based on the achievement of specified revenue and gross profit targets and the success of certain integration activities through 2012. In the fourth quarter of 2011 the company bought out all of its potential obligations for future payments for $3.4 million payable in 2012. Acquisition accounting rules required the Group DCA assets acquired and liabilities assumed to be recorded at their fair value as of the acquisition date. The application of acquisition accounting had a significant impact on reported results in 2011. The company is presenting the following consolidating reconciliation in order to clearly identify the impact of Group DCA's operating results and the buy-out of potential future payments on PDI's continuing operations for the fourth quarter and full year 2011.Reconciliation of Condensed Consolidating Summary of Continuing Operations*($ in millions)For the Quarter Ended December 31, 2011 $'s in millionsLegacyTotalCons.PDI**Group DCAPDI***Revenue, net$
35.9$
2.4$
38.3Gross Profit8.10.68.7Total Operating Expenses6.34.811.1Operating Income (Loss)$
.8$
(4.2)$

'/>"/>

SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
2. Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
3. Stereotaxis Reports 2011 Financial Results; Provides 2012 Milestones
4. ZONARE Reports Fourth Quarter and 2011 Results
5. IRIDEX Reports 2011 Fourth Quarter and Year-End Results
6. Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
7. Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results
8. Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
9. ERT Reports Fourth Quarter and Full Year 2011 Operating Results
10. Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel ... and NASDAQ OMX First North Premier, Stockholm ... received confirmation that its application to list its common stock ... NASDAQ Stock Market, a unit of the NASDAQ OMX Group. ... NASDAQ Capital Market at the opening of trading on August ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
(Date:8/18/2014)... Reportlinker.com announces that a new market ... Russia Bariatric Surgery Devices Market ... Russia Bariatric Surgery Devices Market ... GlobalData,s new report, "Russia Bariatric Surgery Devices ... on the Russia Bariatric Surgery Devices market. The ...
Breaking Medicine Technology:Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12Russia Bariatric Surgery Devices Market Outlook to 2020 2Russia Bariatric Surgery Devices Market Outlook to 2020 3Russia Bariatric Surgery Devices Market Outlook to 2020 4Russia Bariatric Surgery Devices Market Outlook to 2020 5
(Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
(Date:8/20/2014)... August 20, 2014 First Choice ... emergency rooms in the United States, named Richard Daniels, ... FM 685 facility. , “We are pleased to ... director of our second facility in Pflugerville,” said Dr. ... Emergency Room. , Dr. Daniels received his undergraduate ...
(Date:8/20/2014)... What to Do Now for UDI:, ... the Market, **FDAnews Webinar**, Sept. 11, 2014 — 1:30 ... Hospitals and other buyers of devices lose $5 billion ... systems. , Complying with the FDA’s deadlines is important, ... UDI as soon as possible. If devicemakers don’t, ...
(Date:8/19/2014)... Vancouver, WA (PRWEB) August 20, 2014 As ... school, and for themselves to return to the normal routine ... and snacks in tow, Kristen Yarker, MSc, RD encourages ... standard for their kids’ snack time. , Yarker explains, ... need for nutrients. Instead of giving them junk food handouts, ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 What gives skin ... What can soften skin, replenish and nourish it while lightly ... Beauty®. , "Client after client raves about how their skin ... Heshelow, founder of Sublime Beauty®. "The ingredients are very ... use. Simply smooth it over cleansed skin of the ...
Breaking Medicine News(10 mins):Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 3Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 4Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2
... The cost of low health literacy the difference ... abilities to effectively communicate complex medical information is ... a leading biopharmaceutical company. To improve the health literacy ... offer a health literacy study emphasis beginning this fall. ...
... , ... Government Agencies to Increase ROI of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft ... Parabonâ Computation , a veteran provider of extreme-scale grid computing software and services. ...
... ... completed system-wide implementation of a software standardization program at seven hospital laboratories of ... ... , a leading provider of healthcare diagnostic information technology and outreach solutions, has ...
... rare thyroid tumor, but experts say effects in humans ... The U.S. Food and Drug Administration is defending its ... drug, Victoza (liraglutide), even though animal studies suggest it ... , Victoza, among a class of medicines called glucagon-like ...
... 2010) Van Andel Research Institute (VARI) researchers ... treatment that is currently the first line of defense against ... kidney cancer. Most patients who show a positive response ... year of treatment. Kidney cancer is among the 10 ...
... , ST. PETERS, Mo. , Feb. 18 ... Inc., has donated $25,000 to Meds & Food for ... to saving the lives of Haiti ,s malnourished children and ... peanut-based ready-to-use therapeutic food (RUTF) – known in Haiti ...
Cached Medicine News:Health News:MU offers training program to improve health literacy 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 3Health News:VARI findings may help patients with deadly kidney cancer 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 3
... The GoodKnight 420 CPAP System is the ... (CPAP) device on the market. It is ... preserve their lifestyles while complying with therapy. ... 600 sessions of date/time usage data. It ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
Medicine Products: